Latest Continuous Disclosure News

Austal Limited has addressed ASX concerns over its half-year financial report, confirming compliance with accounting standards despite a qualified audit opinion linked to US Department of Defense contractual relief revenue.

Sequoia Financial Group is actively reviewing its retail licensee services, focusing on its subsidiary InterPrac Financial Planning, with potential structural changes or a sale under consideration amid shifting platform provider relationships.

Challenger Limited has lowered its non-binding offer for Pepper Money to $2.25 per share, adjusting for upcoming dividends, marking its final bid amid ongoing negotiations.

IperionX Limited has denied any undisclosed information following a sharp share price drop from $6.93 to $4.58, clarifying its accounting for U.S. government grants amid market volatility.

Dataworks Group Limited reveals ongoing strategic review with several parties engaged, highlighting the value of its self-exclusion technology and regulatory ties. While discussions remain preliminary, the company signals potential for significant strategic moves ahead.

ARC Funds Limited has been suspended from ASX trading due to a failure to maintain the minimum number of directors required by law, raising questions about its governance and future compliance.

Electro Optic Systems Holdings Limited (EOS) has responded to ASX concerns over insufficient details in its December 2025 announcement about a major US$80 million high energy laser contract, prompting a review and update of its continuous disclosure policy.

Manhattan Gold Limited has clarified recent share price and volume spikes, attributing them to strategic corporate communications and a fresh investor research report.

WA Kaolin Limited has responded to ASX queries clarifying that its Q2 FY2026 order book was a demand snapshot, not a sales forecast, and confirmed timely disclosure of a production shortfall linked to plant issues. The company also addressed regulatory notices, affirming no material impact on operations or securities value.

Oncosil Medical Ltd’s OSLOE securities have been suspended from trading by the ASX due to non-compliance with listing rules, raising questions about the company’s next steps.

Atlas Pearls Ltd has disclosed a significant 27% revenue decline and a net loss for the half year ended December 2025, attributing the results to weaker auction outcomes and one-off accounting impacts. The company affirms timely disclosure and compliance with ASX rules amid market sensitivity.

TZ Limited has responded to ASX queries over the deferral of a A$2.75 million debt repayment, asserting the delay was already well disclosed and unlikely to impact its share price materially.